I

ImageneBio Inc
D

IMA

4.07000
USD
-0.10
(-2.40%)
مغلق
آخر تحديث: · متأخرة 15 دقيقة
حجم التداول
1,117
الربح لكل سهم
-4
العائد الربحي
-
P/E
-1
حجم السوق
46,200,426

العنوان: ImageneBio Inc

القطاع: الرعاية الصحية
الصناعة: Biotechnology
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.